Healthcare with Confidence
Urologic Oncologist. Specialist for Prostate Cancer in Israel
Position:Director of Men’s Health Center
Hospital: Assuta Ramat HaHayal Hospital in Tel Aviv
Professor David Margel was first to perform Fusion Biopsy (MRI-guided smart biopsies) in the country. He established Israel’s first screening clinic for male BRCA mutation carriers.
Professor David Margel is consistently listed in Forbes list of the best Israeli doctors
Qualified Medical Consultation, Second Opinion
Qualified Medical Consultation by Urologic Surgeon David Margel
Clinical Focus:
- Pioneer of Fusion Biopsy (MRI-guided smart biopsies) in Israel – first to perform
- Focal therapy for prostate cancer – HIFU, TOOKAD, NanoKnife
- Urologic oncology and complex oncological surgery
- BRCA-related prostate cancer screening and management
- Early detection and personalized treatment of prostate cancer
- Advanced diagnostic technologies in prostate cancer
- Treatment of Bladder Cancer
Surgical Expertise:
- MRI-fusion prostate biopsies
- Focal therapy techniques preserving function while destroying cancer
- Complex urological oncological procedures
- Minimally invasive surgical techniques
Send Your Medical Files Book Consultation Now
Education of Dr. Margel
- Medical Degree (MD): Hebrew University, Jerusalem, Israel
- PhD in Clinical Epidemiology: University of Toronto, Canada
- Focus: Genetics and Prevention
- Urology Residency: Rabin Medical Center (Beilinson Hospital), Petah Tikva, Israel (2003-2010)
- Research Fellowship: Weizmann Institute of Science, Department of Immunology (2008-2010)
- Sub-specialty Fellowship: Uro-Oncology, University of Toronto, Princess Margaret Cancer Center, Canada (2010-2013)
Professional Experience
2022 – Present: Director, Men’s Health Center Assuta Ramat HaHayal Hospital (Rafael Hospital)
- Established comprehensive men’s health services
- Leading innovation in prostate cancer diagnosis and treatment
2021 – Present: International Committee Member American Society of Clinical Oncology (ASCO)
- Contributing to global oncology guidelines and research initiatives
2019 – 2020: ASCO Leadership Program American Society of Clinical Oncology
- Selected for prestigious international leadership development program
2014 – Present: Professor of Urological Surgery Tel Aviv University
- Teaching medical students and residents
- Leading research in prostate cancer epidemiology
2013 – Present: Senior Physician Department of Urology, Rabin Medical Center (Beilinson Hospital)
- Managing multidisciplinary clinic for invasive bladder cancer
- Established unique screening clinic for men with BRCA mutations
- Founder and Director of Epidemiological Service for Cancer at Davidoff Center
2001 – 2003: Senior Military Physician Israel Defense Forces
- Submarine Fleet Medical Officer
- Paratroopers Brigade (Battalion 50) Medical Officer
Research & Publications of prof. David Margel
- Over 145 peer-reviewed publications indexed in PubMed
- Research focus areas:
- Prostate cancer epidemiology and genetics
- BRCA mutations and prostate cancer risk
- Metformin and prostate cancer prevention
- Active surveillance in prostate cancer
- Large database epidemiological studies
- Principal Investigator: “Personalized Prostate Cancer Screening Among Men with High Risk Genetic Predisposition” (ClinicalTrials.gov: NCT02053805)
- Collaborations with:
- Princess Margaret Cancer Center, Toronto
- Clalit Health Services Research Institute
- Israeli Cancer Research Center
Professional Memberships
- Israeli Medical Association
- Israeli Urological Association
- Israeli Association for Gender and Sex-Aware Medicine
- American Society of Clinical Oncology (ASCO) – International Committee Member
- American Urological Association (AUA)
- European Association of Urology (EAU)
- Society of Urologic Oncology
- Canadian Urological Society
Teaching & Mentorship
- Clinical Associate Professor, Tel Aviv University School of Medicine
- Mentor to urology residents and fellows
- International instructor in advanced prostate cancer diagnostics
- Regular speaker at national and international conferences
Awards & Recogrnition
- ASCO Grant recipient for oncology research
- International thought leader in advanced prostate cancer technologies
- Pioneer of multiple innovative techniques in Israel
- Selected for ASCO Leadership Program (2019-2020)
Languages
- Hebrew
- English